QLT initiates phase II study of punctal plug drug delivery system … - FOXBusiness
Published by Google Inc. March 31st, 2008 in Google FDA News, Regulatory AffairsQLT initiates phase II study of punctal plug drug delivery system ... FOXBusiness - Latanoprost is an active ingredient that has been approved by the Food and Drug Administration for reducing elevated intraocular pressure in patients with ... QLT Inc. Begins Patient Recruitment In Phase II Trial Of Punctal ... |